Name:
Dioctyl phthalate 99+%
Synonym:
Di(2-ethylhexyl)phthalate; Di-sec-octyl phthalate; Bis(2-ethylhexyl)-1,2-benzenedicarboxylate; Bis(2-ethylhexyl)phthalate; DOP; Dioctyl phthalate; DEHP
CAS:
117-81-7
Section 1 - Chemical Product
MSDS Name:Dioctyl phthalate 99+%
Synonym:Di(2-ethylhexyl)phthalate; Di-sec-octyl phthalate; Bis(2-ethylhexyl)-1,2-benzenedicarboxylate; Bis(2-ethylhexyl)phthalate; DOP; Dioctyl phthalate; DEHP
Synonym:Di(2-ethylhexyl)phthalate; Di-sec-octyl phthalate; Bis(2-ethylhexyl)-1,2-benzenedicarboxylate; Bis(2-ethylhexyl)phthalate; DOP; Dioctyl phthalate; DEHP
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
| CAS# | Chemical Name | emsds | EINECS# |
| 117-81-7 | Dioctyl phthalate | >99 | 204-211-0 |
| Hazard Symbols: XN Risk Phrases: 40 |
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Possible risks of irreversible effects.
Potential Health Effects
Eye:
May cause mild eye irritation. Causes redness and pain.
Skin:
May cause mild skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause central nervous system depression.
Inhalation:
Material has a low vapor pressure, so exposure to vapor is not likely. Exposure to dioctyl phthalate occurs from spray or mist, rather than from the vapor, unless heat is applied. If the product is heated, misted or sprayed, it may cause irritation of the respiratory tract if inhaled.
Chronic:
DEHP toxicity appears to be a high-dose phenomenon readily demonstrable in some but not all rodent species and strains. Liver toxicity, so characteristic of rodent responses to DEHP, appears to be irrelevant to humans. The carcinogenic response of DEHP has been demonstrated only in one strain of rat and mouse and does not appear to be a feature of toxicity in higher order mammals, especially primates. Reproductive and developmental toxicity, likewise appears to be limited to high-dose effects seen in rodent testing. The relevance to humans of this testing has not been established.
Possible risks of irreversible effects.
Potential Health Effects
Eye:
May cause mild eye irritation. Causes redness and pain.
Skin:
May cause mild skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause central nervous system depression.
Inhalation:
Material has a low vapor pressure, so exposure to vapor is not likely. Exposure to dioctyl phthalate occurs from spray or mist, rather than from the vapor, unless heat is applied. If the product is heated, misted or sprayed, it may cause irritation of the respiratory tract if inhaled.
Chronic:
DEHP toxicity appears to be a high-dose phenomenon readily demonstrable in some but not all rodent species and strains. Liver toxicity, so characteristic of rodent responses to DEHP, appears to be irrelevant to humans. The carcinogenic response of DEHP has been demonstrated only in one strain of rat and mouse and does not appear to be a feature of toxicity in higher order mammals, especially primates. Reproductive and developmental toxicity, likewise appears to be limited to high-dose effects seen in rodent testing. The relevance to humans of this testing has not been established.
Section 4 - FIRST AID MEASURES
Eyes: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Get medical aid.
Skin:
In case of contact, flush skin with plenty of water. Remove contaminated clothing and shoes. Get medical aid if irritation develops and persists. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
Skin:
In case of contact, flush skin with plenty of water. Remove contaminated clothing and shoes. Get medical aid if irritation develops and persists. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Will burn if involved in a fire. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Water or foam may cause frothing. Use water spray to cool fire-exposed containers. Use water spray, dry chemical, carbon dioxide, or chemical foam.
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Will burn if involved in a fire. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Water or foam may cause frothing. Use water spray to cool fire-exposed containers. Use water spray, dry chemical, carbon dioxide, or chemical foam.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation.
Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Use only with adequate ventilation. Avoid breathing vapor or mist.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Wash thoroughly after handling. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Use only with adequate ventilation. Avoid breathing vapor or mist.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits.
Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29CFR 1910.134 or European Standard EN 149. Always use a NIOSH or European Standard EN 149 approved respirator when necessary.
Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits.
Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29CFR 1910.134 or European Standard EN 149. Always use a NIOSH or European Standard EN 149 approved respirator when necessary.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Liquid
Appearance: colourless
Odor: slight odor
pH: Not available.
Vapor Pressure: .00001 mm Hg @25 deg C
Viscosity: 81.4 cps @ 20 deg C
Boiling Point: 384 deg C @ 760 mm Hg
Freezing/Melting Point: -50 deg C
Autoignition Temperature: 390 deg C ( 734.00 deg F)
Flash Point: 199 deg C ( 390.20 deg F)
Explosion Limits, lower: 0.3% @ 474F
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density: .9861 @ 20/20
Molecular Formula: C24H38O4
Molecular Weight: 390.55
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Excess heat.
Incompatibilities with Other Materials:
Oxidizing agents, acids, nitrates, alkalies.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.
Stable under normal temperatures and pressures.
Conditions to Avoid:
Excess heat.
Incompatibilities with Other Materials:
Oxidizing agents, acids, nitrates, alkalies.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 117-81-7: TI0350000 LD50/LC50:
CAS# 117-81-7: Dermal, guinea pig: LD50 = 10 gm/kg; Draize test, rabbit, eye: 500 mg Mild; Draize test, rabbit, eye: 500 mg/24H Mild; Draize test, rabbit, skin: 500 mg/24H Mild; Oral, mouse: LD50 = 1500 mg/kg; Oral, rabbit: LD50 = 34 gm/kg; Oral, rat: LD50 = 30 gm/kg; Skin, rabbit: LD50 = 25 gm/kg.
Carcinogenicity:
Dioctyl phthalate - ACGIH: A3 - Animal Carcinogen California: carcinogen; initial date 1/1/88 NIOSH: occupational carcinogen NTP: Suspect carcinogen OSHA: Possible Select carcinogen IARC: Group 3 carcinogen See actual entry in RTECS for complete information.
CAS# 117-81-7: TI0350000 LD50/LC50:
CAS# 117-81-7: Dermal, guinea pig: LD50 = 10 gm/kg; Draize test, rabbit, eye: 500 mg Mild; Draize test, rabbit, eye: 500 mg/24H Mild; Draize test, rabbit, skin: 500 mg/24H Mild; Oral, mouse: LD50 = 1500 mg/kg; Oral, rabbit: LD50 = 34 gm/kg; Oral, rat: LD50 = 30 gm/kg; Skin, rabbit: LD50 = 25 gm/kg.
Carcinogenicity:
Dioctyl phthalate - ACGIH: A3 - Animal Carcinogen California: carcinogen; initial date 1/1/88 NIOSH: occupational carcinogen NTP: Suspect carcinogen OSHA: Possible Select carcinogen IARC: Group 3 carcinogen See actual entry in RTECS for complete information.
Section 12 - ECOLOGICAL INFORMATION
Other No information available.
Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - TRANSPORT INFORMATION
IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Dangerous Goods Code:
UN Number:
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 40 Possible risks of irreversible effects.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 117-81-7: 1
United Kingdom Occupational Exposure Limits
CAS# 117-81-7: OES-United Kingdom, TWA 5 mg/m3 TWA
CAS# 117-81-7: OES-United Kingdom, STEL 10 mg/m3 STEL
Canada
CAS# 117-81-7 is listed on Canadas DSL List.
CAS# 117-81-7 is listed on Canadas Ingredient Disclosure List.
Exposure Limits
CAS# 117-81-7: OEL-AUSTRALIA:TWA 10 mg/m3
OEL-AUSTRALIA:TWA 5 mg/m3;STEL 10 mg/m3
OEL-BELGIUM:TWA 5 mg/m3;STEL 10 mg/m3
OEL-CZECHOSLOVAKIA:TWA 5 mg/m3;STEL 10 mg/m3 JAN9
OEL-DENMARK:TWA 5 mg/m3
OEL-DENMARK:TWA 5 mg/m3;Carcinogen
OEL-FINLAND:TWA 5 mg/m3;STEL 10 mg/m3;Skin
OEL-FRANCE:TWA 5 mg/m3
OEL-GERMANY:TWA 10 mg/m3
OEL-HUNGARY:TWA 5 mg/m3;STEL 10 mg/m3;Skin
OEL-THE NETHERLANDS:TWA 5 mg/m3
OEL-THE PHILIPPINES:TWA 5 mg/m3
OEL-RUSSIA:STEL 1 mg/m3
OEL-SWEDEN
OEL-SWEDEN:TWA 3 mg/m3;STEL 5 mg/m3
OEL-SWITZERLAND:TWA 5 mg/m3
OEL-UNITED KINGDOM:TWA 5 mg/m3;STEL 10 mg/m3 JAN9
OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV
OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGI TLV
US FEDERAL
TSCA
CAS# 117-81-7 is listed on the TSCA inventory.
